SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-146091
Filing Date
2023-05-16
Accepted
2023-05-16 16:06:08
Documents
13
Period of Report
2023-05-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d468524d8k.htm   iXBRL 8-K 38886
2 EX-3.1 d468524dex31.htm EX-3.1 5361
  Complete submission text file 0001193125-23-146091.txt   177202

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20230511.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20230511_lab.xml EX-101.LAB 19483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20230511_pre.xml EX-101.PRE 12154
7 EXTRACTED XBRL INSTANCE DOCUMENT d468524d8k_htm.xml XML 3726
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 23927482
SIC: 2836 Biological Products, (No Diagnostic Substances)